|
1
|
2010 U.S. Type 2 Diabetes Patients'
Choice: Awareness. Usage, and Preferences of Insulin Injection
Pens. Frost & Sullivan. 2011.
|
|
2
|
Rensing KL, Reuwer AQ, Arsenault BJ, von
der Thüsen JH, Hoekstra JB, Kastelein JJ and Twickler TB: Reducing
cardiovascular disease risk in patients with type 2 diabetes and
concomitant macrovascular disease: can insulin be too much of a
good thing? Diabetes Obes Metab. 13:1073–1087. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yanase M, Takatsu F, Tagawa T, Kato T,
Arai K, Koyasu M, Horibe H, Nomoto S, Takemoto K, Shimizu S and
Watarai M: Insulin resistance and fasting hyperinsulinemia are risk
factors for new cardiovascular events in patients with prior
coronary artery disease and normal glucose tolerance. Circ J.
68:47–52. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Caccamo G, Bonura F, Bonura F, Vitale G,
Novo G, Evola S, Evola G, Grisanti MR and Novo S: Insulin
resistance and acute coronary syndrome. Atherosclerosis.
211:672–675. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Breen DM and Giacca A: Effects of insulin
on the vasculature. Curr Vasc Pharmacol. 9:321–332. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kuboki K, Jiang ZY, Takahara N, Ha SW,
Igarashi M, Yamauchi T, Feener EP, Herbert TP, Rhodes CJ and King
GL: Regulation of endothelial constitutive nitric oxide synthase
gene expression in endothelial cells and in vivo: a specific
vascular action of insulin. Circulation. 101:676–681. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chinese Diabetes Society (CDS): Chinese
guideline for type 2 diabetes prevention (2013). Chin J Diab.
22:2–42. 2014.(In Chinese).
|
|
8
|
Leahy JL and Cefalu WT: Insulin Therapy.
Marcel Dekker, Inc. New York, NY: 193–222. 2002.
|
|
9
|
Permana H: How to initiate and
intensification of insulin therapy in type 2 DM patients with
obesity? Obes Res Clin Pract J. 7(Suppl 1): 7–8. 2013. View Article : Google Scholar
|
|
10
|
No authors listed: Summary of revisions
for the 2009 Clinical Practice Recommendations. Diabetes Care.
32(Suppl 1): S3–S5. 2009.PubMed/NCBI
|
|
11
|
Endocrinology society of Chinese Medical
Association: Chinese expert consensus on the clinical application
of adult type 2 diabetes insulin. Chin J Endocrinol Metab. 29:1–6.
2013.
|
|
12
|
Albacker T, Carvalho G, Schricker T and
Lachapelle K: High-dose insulin therapy attenuates systemic
inflammatory response in coronary artery bypass grafting patients.
Ann Thorac Surg. 86:20–27. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Owens DR: Stepwise intensification of
insulin therapy in type 2 diabetes management - exploring the
concept of the basal-plus approach in clinical practice. Diabet
Med. 30:276–288. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Albacker TB, Carvalho G, Schricker T and
Lachapelle K: Myocardial protection during elective coronary artery
bypass grafting using high-dose insulin therapy. Ann Thorac Surg.
84:1920–1927. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mahajan R, Daga MK and Bhattacharjee J:
Hyperinsulinemia in subjects with and without coronary artery
disease: a preliminary study from North India. Indian Heart J.
54:687–691. 2002.PubMed/NCBI
|
|
16
|
Chistiakov DA, Sobenin IA, Orekhov AN and
Bobryshev YV: Mechanisms of medial arterial calcification in
diabetes. Curr Pharm Des. 20:5870–5883. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Siddals KW, Allen J, Sinha S, Canfield AE,
Kalra PA and Gibson JM: Apposite insulin-like growth factor (IGF)
receptor glycosylation is critical to the maintenance of vascular
smooth muscle phenotype in the presence of factors promoting
osteogenic differentiation and mineralization. J Biol Chem.
286:16623–16630. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim JA, Montagnani M, Koh KK and Quon MJ:
Reciprocal relationships between insulin resistance and endothelial
dysfunction: molecular and pathophysiological mechanisms.
Circulation. 113:1888–1904. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Purohit P: A correlation study of CVD risk
factors in Type 2 diabetics of Western Rajasthan. Int J Diabetes
Dev Ctries. 190–197. 2014.
|
|
20
|
Adiels M, Borén J, Caslake MJ, Stewart P,
Soro A, Westerbacka J, Wennberg B, Olofsson SO, Packard C and
Taskinen MR: Overproduction of VLDL1 driven by hyperglycemia is a
dominant feature of diabetic dyslipidemia. Arterioscler Thromb Vasc
Biol. 25:1697–1703. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tangvarasittichai S, Poonsub P and
Tangvarasittichai O: Association of serum lipoprotein ratios with
insulin resistance in type 2 diabetes mellitus. Indian J Med Res.
131:641–648. 2010.PubMed/NCBI
|
|
22
|
Hill MM, Connolly LM, Simpson RJ and James
DE: Differential protein phosphorylation in 3T3-L1 adipocytes in
response to insulin versus platelet-derived growth factor. No
evidence for a phosphatidylinositide 3-kinase-independent pathway
in insulin signaling. J Biol Chem. 275:24313–24320. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Abhijit S, Bhaskaran R, Narayanasamy A,
Chakroborty A, Manickam N, Dixit M, Mohan V and Balasubramanyam M:
Hyperinsulinemia-induced vascular smooth muscle cell (VSMC)
migration and proliferation is mediated by converging mechanisms of
mitochondrial dysfunction and oxidative stress. Mol Cell Biochem.
373:95–105. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cohen P: The twentieth century struggle to
decipher insulin signalling. Nat Rev Mol Cell Biol. 7:867–873.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ning J and Clemmons DR: AMP-activated
protein kinase inhibits IGF-I signaling and protein synthesis in
vascular smooth muscle cells via stimulation of insulin receptor
substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.
Mol Endocrinol. 24:1218–1229. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Isenović ER, Kedees MH, Tepavcević S,
Milosavljević T, Korićanac G, Trpković A and Marche P: Role of
PI3K/AKT, cPLA2 and ERK1/2 signaling pathways in insulin regulation
of vascular smooth muscle cells proliferation. Cardiovasc Hematol
Disord Drug Targets. 9:172–180. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Doronzo G, Viretto M, Russo I, et al:
Insulin increases matrix metalloproteinase-2 synthesis, secretion
and activity in aortic vascular smooth muscle cells through the
PI3-K pathway: effect reduced by insulin resistance. Diabetologia.
51:S253–S254. 2008.
|
